MoneyWorks4Me

Lupin informs about earnings call transcript

14 Feb 2020 Evaluate

Lupin has informed that pursuant to Regulation 30(2) read with Schedule III Part A(15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosed a copy of the Transcript of the Q3 FY20 Earnings Conference Call on Thursday, February 6, 2020 at Mumbai.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..